BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 19375969)

  • 41. Erythropoiesis: model systems, molecular regulators, and developmental programs.
    Tsiftsoglou AS; Vizirianakis IS; Strouboulis J
    IUBMB Life; 2009 Aug; 61(8):800-30. PubMed ID: 19621348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recipient-derived clots in red blood cells during transfusion.
    Wagner T; Macher S; Kröll W; Jüngling G; Lanzer G; Gabriel C
    Transfusion; 2006 Sep; 46(9):1646. PubMed ID: 16965595
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of perfluorane in the transfusion therapy of tuberculosis and other bronchopulmonary diseases].
    Zhilin IuN; Bakhmutova NV; Gamaev AE; Nabokova TS; Kaminskaia GO; Serebriannaia BA; Gus'kov MIu
    Probl Tuberk; 2000; (1):18-21. PubMed ID: 10750422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The three "R"s of blood transfusion in 2020; routine, reliable and robust.
    Abbot S
    Clin Lab Med; 2010 Jun; 30(2):405-17. PubMed ID: 20513559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current issues relating to the transfusion of stored red blood cells.
    Zimrin AB; Hess JR
    Vox Sang; 2009 Feb; 96(2):93-103. PubMed ID: 19152602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lancet Technology: pharming blood.
    Lee N
    Lancet; 2016 Jun; 387(10037):2496. PubMed ID: 27353675
    [No Abstract]   [Full Text] [Related]  

  • 47. Ex-vivo generation of human red cells for transfusion.
    Anstee DJ; Gampel A; Toye AM
    Curr Opin Hematol; 2012 May; 19(3):163-9. PubMed ID: 22406823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion.
    Garratty G
    Vox Sang; 2008 Feb; 94(2):87-95. PubMed ID: 18034787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological validation of bio-engineered red blood cell productions.
    Giarratana MC; Marie T; Darghouth D; Douay L
    Blood Cells Mol Dis; 2013 Feb; 50(2):69-79. PubMed ID: 23040561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Red cell transfusion in medicine: future challenges.
    Novotny VM
    Transfus Clin Biol; 2007 Dec; 14(6):538-41. PubMed ID: 18359656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent advance on blood group antigen modification of porcine erythrocytes].
    Wang JX; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):273-6. PubMed ID: 12513803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.
    McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD
    Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Industrially Compatible Transfusable iPSC-Derived RBCs: Progress, Challenges and Prospective Solutions.
    Lim ZR; Vassilev S; Leong YW; Hang JW; Rénia L; Malleret B; Oh SK
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral blood stem cell recovery following early termination of apheresis due to hypotension in a 4.8-kg infant.
    Alex J; Bahl MJ; Schlueter AJ
    J Clin Apher; 2009; 24(3):120-1. PubMed ID: 19253358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manufactured RBC--rivers of blood, or an oasis in the desert?
    Timmins NE; Nielsen LK
    Biotechnol Adv; 2011; 29(6):661-6. PubMed ID: 21609758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes.
    Bradley AJ; Scott MD
    Am J Hematol; 2007 Nov; 82(11):970-5. PubMed ID: 17654505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Large-scale in-vitro expansion of RBCs from hematopoietic stem cells.
    Ramesh B; Guhathakurta S
    Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):42-51. PubMed ID: 22834784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfusion of aged packed red blood cells results in decreased tissue oxygenation in critically injured trauma patients.
    Kiraly LN; Underwood S; Differding JA; Schreiber MA
    J Trauma; 2009 Jul; 67(1):29-32. PubMed ID: 19590304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.